Dr. Sarika Wairkar, Associate Professor at SVKM’s NMIMS Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management (popularly known as SPPSPTM), has recently been granted the Indian patent No. 408059 for her research work titled- ‘Topical Foam Composition Comprising Mupirocin’.
Her invention is related to the foam formulation of Mupirocin - a commonly used topical antibiotic in traumatic skin lesions and burn wounds. Currently, Mupirocin is commercially available as a cream formulation which needs to be applied by touching the skin or wound surface.
Dr. Sarika Wairkar from SPPSPTM has prepared Mupirocin foam for topical application with quick collapse time, good spreadability, and superior antibacterial efficacy. It can be easily applied to the desired area without touching the wound. After the successful conduct of clinical trials, it has been established that this formulation can be used as an alternative to the conventional topical dosage form.
Furthermore, Dr Sarika Wairkar, Associate Professor, SPPSPTM, NMIMS, has clarified that this formulation was designed considering severe pain and infection of critical wounds, especially burn wounds where the application of medicine is a difficult task. As a result, this formulation may substantially help in the management of chronic wounds.
On this occasion, the Dean of SPPSPTM, Dr Bala Prabhakar spoke about the school’s continued thrust on ground-breaking research. For people unversed, SPPSPTM was established under the aegis of SVKM’s NMIMS in 2006 as a pharmacy school, offering doctoral, postgraduate, graduate and diploma programmes in pharmaceutical sciences. The school is a pioneer in introducing integrated programmes in pharmacy and technology management.
Mohali (Punjab)
Indore (Madhya Pradesh)
Nashik (Maharashtra)
Coimbatore (Tamil Nadu)

The CUET B.Pharm Syllabus 2026 is intended to evaluate candidates' scientific ability and academic readiness for a Bachelor of Pharmacy program. The CUET UG 2026 exam is conducted by the National Testing Agency (NTA), provides a uniform framework for admission to undergraduate pharmacy programs at central, state, deemed, and private universities throughout India. By detailing the subject-specific themes, learning objectives, and knowledge areas that are critical for exam achievement, the syllabus of CUET B.Pharm plays a critical role in directing candidates toward concentrated preparation. Candidates must take note that the CUET B.Pharm syllabus 2026 consists of the language test, general aptitude test and the domain subject test. The syllabus for CUET B.Pharm 2026 is mainly in line with the curriculum for Classes 11 and 12, guaranteeing that students are tested on ideas they have previously learned at the senior secondary level. As the academic cornerstone of pharmacy education, physics, chemistry, and biology/mathematics are typically included in the core domain subjects. The application of theoretical concepts, problem-solving skills, and an awareness of basic scientific principles are emphasized, all of which are essential for pharmaceutical research.

List of Do's and Don'ts for GPAT 2026 Registration: It is important to know how to correctly fill out the GPAT Registration form because many applications get cancelled each year. There are many reasons the GPAT 2026 Registration form could be rejected. The GPAT application from 2026 can take time, so you might make mistakes while completing the application.

Pharmacy students in India follow a gradual process of growth. They take BPharm at the undergraduate level, then proceed to MPharm. But MPharm admissions don’t come easy. BPharm graduates have to take an entrance test if they want admission to MPharm programs. That national-level entrance test is GPAT (Graduate Pharmacy Aptitude Test). This exam secures admissions and helps students get financial support for their postgraduation. It qualifies you for AICTE postgraduate scholarships or stipends for up to INR 12,400 per month.

For many B Pharm graduates in India, M Pharm will be the next step to success. Whether you want any specialisation, better job opportunities, research exposure, or academic growth, you have to pursue the M Pharma. However, one exam often stands between students and their postgraduate plans, that is GPAT. Every year, thousands of students ask the same anxious question: “Can I do M Pharm without a GPAT?” The short answer is yes, you can pursue M Pharm without GPAT, but the full picture is more nuanced. The involvement of GPAT determines the varying admission processes, costs, colleges, and career prospects. This article will explain everything in a very easy way so that you will be able to decide without any confusion or fear.
Also Check - How to upload category certificate in GPAT 2026 application form?

Filling out the GPAT application form 2026 is already a stressful task for many pharmacy aspirants. Between uploading documents, choosing exam cities, and paying the fee, it’s easy to overlook one small but extremely important step is signature verification. Many students assume that once the signature is uploaded, the job is done. Unfortunately, that’s not always true. Most of the candidates get rejected every year if the signature uploaded does not meet the criteria mentioned.